Industry Research Reports
Home > Reports > Service & Software > Global ELISpot Assay Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Global ELISpot Assay Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-11
Pages: 141 Pages
Report ld: 6174146
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
ELISpot Assay Service Market Size(US$)
CAGR 2026-2032
4.2%
Market Size,2032
USD 656
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 512 million
Market Forecast in 2032(Value)
US$ 656 million
CAGR
4.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global ELISpot Assay Service market is projected to grow from US$ 494 million in 2025 to US$ 656 million by 2032, at a CAGR of 4.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
ELISpot Assay Service refers to a laboratory-based analytical service that utilizes the Enzyme-Linked ImmunoSpot (ELISpot) technique to detect and quantify individual cells secreting specific cytokines, antibodies, or other immune-related molecules. This highly sensitive assay enables researchers to assess cellular immune responses at the single-cell level, making it a valuable tool for vaccine development, immunotherapy evaluation, and infectious disease research. The service typically includes assay optimization, sample preparation, stimulation protocols, plate reading, and detailed data analysis. ELISpot assays are especially useful for monitoring T-cell and B-cell responses, allowing scientists to identify rare but functionally relevant immune cells. Used extensively in both preclinical and clinical research settings, ELISpot Assay Services provide critical insights into immune function, treatment efficacy, and disease progression.
From a downstream perspective, Academic and Research Institutions accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
ELISpot Assay Service leading players (including Synexa Life Sciences, Precision for Medicine, JPT Peptide Technologies, ImmunoSpot, Creative Biolabs, Creative Proteomics, RayBiotech, Accelevir Diagnostics, Crown Bioscience, Eurofins Viracor, etc.), dominate supply; the top five capture approximately % of global revenue, with Synexa Life Sciences leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global ELISpot Assay Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Synexa Life Sciences
- Precision for Medicine
- JPT Peptide Technologies
- ImmunoSpot
- Creative Biolabs
- Creative Proteomics
- RayBiotech
- Accelevir Diagnostics
- Crown Bioscience
- Eurofins Viracor
- ProImmune
- ImmunitasBio
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single-Color ELISpot
- Multi-Color ELISpot
Segment by Application
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Clinical and Diagnostic Laboratories
- Government and Regulatory Agencies
- Others
CHAPTER OUTLINE
Chapter 1: Defines the ELISpot Assay Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to ELISpot Assay Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global ELISpot Assay Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Single-Color ELISpot
1.2.3 Multi-Color ELISpot
1.3 Market Segmentation by Application
1.3.1 Global ELISpot Assay Service Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Academic and Research Institutions
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Clinical and Diagnostic Laboratories
1.3.5 Government and Regulatory Agencies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ELISpot Assay Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global ELISpot Assay Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global ELISpot Assay Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global ELISpot Assay Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Single-Color ELISpot: Market Share by Key Players
3.3.2 Multi-Color ELISpot: Market Share by Key Players
3.4 Global ELISpot Assay Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global ELISpot Assay Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global ELISpot Assay Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America ELISpot Assay Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America ELISpot Assay Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe ELISpot Assay Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe ELISpot Assay Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific ELISpot Assay Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific ELISpot Assay Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America ELISpot Assay Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America ELISpot Assay Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa ELISpot Assay Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa ELISpot Assay Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Synexa Life Sciences
11.1.1 Synexa Life Sciences Corporation Information
11.1.2 Synexa Life Sciences Business Overview
11.1.3 Synexa Life Sciences ELISpot Assay Service Product Features and Attributes
11.1.4 Synexa Life Sciences ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.1.5 Synexa Life Sciences ELISpot Assay Service Revenue by Product in 2025
11.1.6 Synexa Life Sciences ELISpot Assay Service Revenue by Application in 2025
11.1.7 Synexa Life Sciences ELISpot Assay Service Revenue by Geographic Area in 2025
11.1.8 Synexa Life Sciences ELISpot Assay Service SWOT Analysis
11.1.9 Synexa Life Sciences Recent Developments
11.2 Precision for Medicine
11.2.1 Precision for Medicine Corporation Information
11.2.2 Precision for Medicine Business Overview
11.2.3 Precision for Medicine ELISpot Assay Service Product Features and Attributes
11.2.4 Precision for Medicine ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.2.5 Precision for Medicine ELISpot Assay Service Revenue by Product in 2025
11.2.6 Precision for Medicine ELISpot Assay Service Revenue by Application in 2025
11.2.7 Precision for Medicine ELISpot Assay Service Revenue by Geographic Area in 2025
11.2.8 Precision for Medicine ELISpot Assay Service SWOT Analysis
11.2.9 Precision for Medicine Recent Developments
11.3 JPT Peptide Technologies
11.3.1 JPT Peptide Technologies Corporation Information
11.3.2 JPT Peptide Technologies Business Overview
11.3.3 JPT Peptide Technologies ELISpot Assay Service Product Features and Attributes
11.3.4 JPT Peptide Technologies ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.3.5 JPT Peptide Technologies ELISpot Assay Service Revenue by Product in 2025
11.3.6 JPT Peptide Technologies ELISpot Assay Service Revenue by Application in 2025
11.3.7 JPT Peptide Technologies ELISpot Assay Service Revenue by Geographic Area in 2025
11.3.8 JPT Peptide Technologies ELISpot Assay Service SWOT Analysis
11.3.9 JPT Peptide Technologies Recent Developments
11.4 ImmunoSpot
11.4.1 ImmunoSpot Corporation Information
11.4.2 ImmunoSpot Business Overview
11.4.3 ImmunoSpot ELISpot Assay Service Product Features and Attributes
11.4.4 ImmunoSpot ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.4.5 ImmunoSpot ELISpot Assay Service Revenue by Product in 2025
11.4.6 ImmunoSpot ELISpot Assay Service Revenue by Application in 2025
11.4.7 ImmunoSpot ELISpot Assay Service Revenue by Geographic Area in 2025
11.4.8 ImmunoSpot ELISpot Assay Service SWOT Analysis
11.4.9 ImmunoSpot Recent Developments
11.5 Creative Biolabs
11.5.1 Creative Biolabs Corporation Information
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs ELISpot Assay Service Product Features and Attributes
11.5.4 Creative Biolabs ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.5.5 Creative Biolabs ELISpot Assay Service Revenue by Product in 2025
11.5.6 Creative Biolabs ELISpot Assay Service Revenue by Application in 2025
11.5.7 Creative Biolabs ELISpot Assay Service Revenue by Geographic Area in 2025
11.5.8 Creative Biolabs ELISpot Assay Service SWOT Analysis
11.5.9 Creative Biolabs Recent Developments
11.6 Creative Proteomics
11.6.1 Creative Proteomics Corporation Information
11.6.2 Creative Proteomics Business Overview
11.6.3 Creative Proteomics ELISpot Assay Service Product Features and Attributes
11.6.4 Creative Proteomics ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.6.5 Creative Proteomics Recent Developments
11.7 RayBiotech
11.7.1 RayBiotech Corporation Information
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech ELISpot Assay Service Product Features and Attributes
11.7.4 RayBiotech ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.7.5 RayBiotech Recent Developments
11.8 Accelevir Diagnostics
11.8.1 Accelevir Diagnostics Corporation Information
11.8.2 Accelevir Diagnostics Business Overview
11.8.3 Accelevir Diagnostics ELISpot Assay Service Product Features and Attributes
11.8.4 Accelevir Diagnostics ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.8.5 Accelevir Diagnostics Recent Developments
11.9 Crown Bioscience
11.9.1 Crown Bioscience Corporation Information
11.9.2 Crown Bioscience Business Overview
11.9.3 Crown Bioscience ELISpot Assay Service Product Features and Attributes
11.9.4 Crown Bioscience ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.9.5 Crown Bioscience Recent Developments
11.10 Eurofins Viracor
11.10.1 Eurofins Viracor Corporation Information
11.10.2 Eurofins Viracor Business Overview
11.10.3 Eurofins Viracor ELISpot Assay Service Product Features and Attributes
11.10.4 Eurofins Viracor ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 ProImmune
11.11.1 ProImmune Corporation Information
11.11.2 ProImmune Business Overview
11.11.3 ProImmune ELISpot Assay Service Product Features and Attributes
11.11.4 ProImmune ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.11.5 ProImmune Recent Developments
11.12 ImmunitasBio
11.12.1 ImmunitasBio Corporation Information
11.12.2 ImmunitasBio Business Overview
11.12.3 ImmunitasBio ELISpot Assay Service Product Features and Attributes
11.12.4 ImmunitasBio ELISpot Assay Service Revenue and Gross Margin (2021-2026)
11.12.5 ImmunitasBio Recent Developments
12 ELISpot Assay Service Value Chain and Ecosystem Analysis
12.1 ELISpot Assay Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 ELISpot Assay Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global ELISpot Assay Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global ELISpot Assay Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global ELISpot Assay Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global ELISpot Assay Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global ELISpot Assay Service Revenue by Region (US$ Million), 2021-2026
Table 5. Global ELISpot Assay Service Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global ELISpot Assay Service Revenue by Players (US$ Million), 2021-2026
Table 8. Global ELISpot Assay Service Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on ELISpot Assay Service Revenue, 2025
Table 11. Global ELISpot Assay Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global ELISpot Assay Service Companies Headquarters
Table 13. Global ELISpot Assay Service Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global ELISpot Assay Service Revenue by Type (US$ Million), 2021-2026
Table 17. Global ELISpot Assay Service Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global ELISpot Assay Service Revenue by Application (US$ Million), 2021-2026
Table 20. Global ELISpot Assay Service Revenue by Application (US$ Million), 2027-2032
Table 21. ELISpot Assay Service High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America ELISpot Assay Service Growth Accelerators and Market Barriers
Table 25. North America ELISpot Assay Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe ELISpot Assay Service Growth Accelerators and Market Barriers
Table 27. Europe ELISpot Assay Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific ELISpot Assay Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific ELISpot Assay Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America ELISpot Assay Service Investment Opportunities and Key Challenges
Table 31. Central and South America ELISpot Assay Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa ELISpot Assay Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa ELISpot Assay Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Synexa Life Sciences Corporation Information
Table 35. Synexa Life Sciences Description and Major Businesses
Table 36. Synexa Life Sciences Product Features and Attributes
Table 37. Synexa Life Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Synexa Life Sciences Revenue Proportion by Product in 2025
Table 39. Synexa Life Sciences Revenue Proportion by Application in 2025
Table 40. Synexa Life Sciences Revenue Proportion by Geographic Area in 2025
Table 41. Synexa Life Sciences ELISpot Assay Service SWOT Analysis
Table 42. Synexa Life Sciences Recent Developments
Table 43. Precision for Medicine Corporation Information
Table 44. Precision for Medicine Description and Major Businesses
Table 45. Precision for Medicine Product Features and Attributes
Table 46. Precision for Medicine Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Precision for Medicine Revenue Proportion by Product in 2025
Table 48. Precision for Medicine Revenue Proportion by Application in 2025
Table 49. Precision for Medicine Revenue Proportion by Geographic Area in 2025
Table 50. Precision for Medicine ELISpot Assay Service SWOT Analysis
Table 51. Precision for Medicine Recent Developments
Table 52. JPT Peptide Technologies Corporation Information
Table 53. JPT Peptide Technologies Description and Major Businesses
Table 54. JPT Peptide Technologies Product Features and Attributes
Table 55. JPT Peptide Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. JPT Peptide Technologies Revenue Proportion by Product in 2025
Table 57. JPT Peptide Technologies Revenue Proportion by Application in 2025
Table 58. JPT Peptide Technologies Revenue Proportion by Geographic Area in 2025
Table 59. JPT Peptide Technologies ELISpot Assay Service SWOT Analysis
Table 60. JPT Peptide Technologies Recent Developments
Table 61. ImmunoSpot Corporation Information
Table 62. ImmunoSpot Description and Major Businesses
Table 63. ImmunoSpot Product Features and Attributes
Table 64. ImmunoSpot Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. ImmunoSpot Revenue Proportion by Product in 2025
Table 66. ImmunoSpot Revenue Proportion by Application in 2025
Table 67. ImmunoSpot Revenue Proportion by Geographic Area in 2025
Table 68. ImmunoSpot ELISpot Assay Service SWOT Analysis
Table 69. ImmunoSpot Recent Developments
Table 70. Creative Biolabs Corporation Information
Table 71. Creative Biolabs Description and Major Businesses
Table 72. Creative Biolabs Product Features and Attributes
Table 73. Creative Biolabs Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Creative Biolabs Revenue Proportion by Product in 2025
Table 75. Creative Biolabs Revenue Proportion by Application in 2025
Table 76. Creative Biolabs Revenue Proportion by Geographic Area in 2025
Table 77. Creative Biolabs ELISpot Assay Service SWOT Analysis
Table 78. Creative Biolabs Recent Developments
Table 79. Creative Proteomics Corporation Information
Table 80. Creative Proteomics Description and Major Businesses
Table 81. Creative Proteomics Product Features and Attributes
Table 82. Creative Proteomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Creative Proteomics Recent Developments
Table 84. RayBiotech Corporation Information
Table 85. RayBiotech Description and Major Businesses
Table 86. RayBiotech Product Features and Attributes
Table 87. RayBiotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. RayBiotech Recent Developments
Table 89. Accelevir Diagnostics Corporation Information
Table 90. Accelevir Diagnostics Description and Major Businesses
Table 91. Accelevir Diagnostics Product Features and Attributes
Table 92. Accelevir Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Accelevir Diagnostics Recent Developments
Table 94. Crown Bioscience Corporation Information
Table 95. Crown Bioscience Description and Major Businesses
Table 96. Crown Bioscience Product Features and Attributes
Table 97. Crown Bioscience Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Crown Bioscience Recent Developments
Table 99. Eurofins Viracor Corporation Information
Table 100. Eurofins Viracor Description and Major Businesses
Table 101. Eurofins Viracor Product Features and Attributes
Table 102. Eurofins Viracor Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Eurofins Viracor Recent Developments
Table 104. ProImmune Corporation Information
Table 105. ProImmune Description and Major Businesses
Table 106. ProImmune Product Features and Attributes
Table 107. ProImmune Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. ProImmune Recent Developments
Table 109. ImmunitasBio Corporation Information
Table 110. ImmunitasBio Description and Major Businesses
Table 111. ImmunitasBio Product Features and Attributes
Table 112. ImmunitasBio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. ImmunitasBio Recent Developments
Table 114. Technologies, Platforms and Infrastructure
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ELISpot Assay Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Single-Color ELISpot Product Picture
Figure 3. Multi-Color ELISpot Product Picture
Figure 4. Global ELISpot Assay Service Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 5. Global ELISpot Assay Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Academic and Research Institutions
Figure 7. Pharmaceutical and Biotechnology Companies
Figure 8. Clinical and Diagnostic Laboratories
Figure 9. Government and Regulatory Agencies
Figure 10. Others
Figure 11. ELISpot Assay Service Report Years Considered
Figure 12. Global ELISpot Assay Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 14. Global ELISpot Assay Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global ELISpot Assay Service Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global ELISpot Assay Service Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. Single-Color ELISpot Revenue-Based Market Share by Player in 2025
Figure 19. Multi-Color ELISpot Revenue-Based Market Share by Player in 2025
Figure 20. Global ELISpot Assay Service Revenue-Based Market Share by Type (2021-2032)
Figure 21. Global ELISpot Assay Service Revenue-Based Market Share by Application (2021-2032)
Figure 22. North America ELISpot Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 23. North America Top 5 Players ELISpot Assay Service Revenue (US$ Million) in 2025
Figure 24. North America ELISpot Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 25. US ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 26. Canada ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 27. Mexico ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 28. Europe ELISpot Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 29. Europe Top 5 Players ELISpot Assay Service Revenue (US$ Million) in 2025
Figure 30. Europe ELISpot Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 31. Germany ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 32. France ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 33. U.K. ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 34. Italy ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 35. Russia ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 36. Asia-Pacific ELISpot Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 37. Asia-Pacific Top 8 Players ELISpot Assay Service Revenue (US$ Million) in 2025
Figure 38. Asia-Pacific ELISpot Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 39. Indonesia ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 40. Japan ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 41. South Korea ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 42. Australia ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 43. India ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 44. Indonesia ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 45. Vietnam ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 46. Malaysia ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 47. Philippines ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 48. Singapore ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 49. Central and South America ELISpot Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 50. Central and South America Top 5 Players ELISpot Assay Service Revenue (US$ Million) in 2025
Figure 51. Central and South America ELISpot Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 52. Brazil ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 53. Argentina ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 54. Middle East and Africa ELISpot Assay Service Revenue YoY (US$ Million), 2021-2032
Figure 55. Middle East and Africa Top 5 Players ELISpot Assay Service Revenue (US$ Million) in 2025
Figure 56. Middle East and Africa ELISpot Assay Service Revenue (US$ Million) by Application (2021-2032)
Figure 57. GCC Countries ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 58. Israel ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 59. Egypt ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 60. South Africa ELISpot Assay Service Revenue (US$ Million), 2021-2032
Figure 61. ELISpot Assay Service Value Chain Mapping
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global ELISpot Assay Service market size from 2026 to 2032?
The annual compound growth rate of the global ELISpot Assay Service market is 4.2% 2026 to 2032.
Which companies rank high in the global ELISpot Assay Service market?
Which region is expected to have the highest market share?
What was the global market size of ELISpot Assay Service in 2032?
What was the global market size of ELISpot Assay Service in 2026?
Related Reports
Global ELISpot Assay Service Market Research Report 2026
The global ELISpot Assay Service market was valued at US$ 494 million in 2025 and is anticipated to reach US$ 656 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 115
USD 2900.00
(Single User License)
Global ELISpot Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global ELISpot Assay Service market size was US$ 494 million in 2025 and is forecast to reach a readjusted size of US$ 656 million by 2032 with a CAGR of 4.2% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 99
USD 4250.00
(Single User License)
ELISpot Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for ELISpot Assay Service was estimated to be worth US$ 494 million in 2025 and is projected to reach US$ 656 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 110
USD 3950.00
(Single User License)
Global ELISpot Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global ELISpot Assay Service market size was US$ 474 million in 2024 and is forecast to a readjusted size of US$ 632 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 94
USD 4250.00
(Single User License)
Global ELISpot Assay Service Market Research Report 2025
The global market for ELISpot Assay Service was valued at US$ 474 million in the year 2024 and is projected to reach a revised size of US$ 632 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published Date: 2025-04-25
Pages: 83
USD 2900.00
(Single User License)
ELISpot Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for ELISpot Assay Service was estimated to be worth US$ 474 million in 2024 and is forecast to a readjusted size of US$ 632 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 114
USD 3950.00
(Single User License)
Global ELISpot Assay Service Market Insights, Forecast to 2031
The global ELISpot Assay Service market is projected to grow from US$ 494 million in 2025 to US$ 632 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
Published Date: 2025-04-25
Pages: 141
USD 4900.00
(Single User License)
Global ELISpot Assay Service Market Research Report 2026
The global ELISpot Assay Service market was valued at US$ 494 million in 2025 and is anticipated to reach US$ 656 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-03-11
Pages: 115
USD 2900.00 (Single User License)Global ELISpot Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global ELISpot Assay Service market size was US$ 494 million in 2025 and is forecast to reach a readjusted size of US$ 656 million by 2032 with a CAGR of 4.2% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 99
USD 4250.00 (Single User License)ELISpot Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for ELISpot Assay Service was estimated to be worth US$ 494 million in 2025 and is projected to reach US$ 656 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 110
USD 3950.00 (Single User License)Global ELISpot Assay Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global ELISpot Assay Service market size was US$ 474 million in 2024 and is forecast to a readjusted size of US$ 632 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 94
USD 4250.00 (Single User License)Global ELISpot Assay Service Market Research Report 2025
The global market for ELISpot Assay Service was valued at US$ 474 million in the year 2024 and is projected to reach a revised size of US$ 632 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published: 2025-04-25
Pages: 83
USD 2900.00 (Single User License)ELISpot Assay Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for ELISpot Assay Service was estimated to be worth US$ 474 million in 2024 and is forecast to a readjusted size of US$ 632 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 114
USD 3950.00 (Single User License)Global ELISpot Assay Service Market Insights, Forecast to 2031
The global ELISpot Assay Service market is projected to grow from US$ 494 million in 2025 to US$ 632 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
Published: 2025-04-25
Pages: 141
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now